Inventor
Danny J. Garland
Inventor
Ballwin, MO, US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds43%
C07CAcyclic or carbocyclic compounds14%
PatentTitleYear
10,815,213Bruton's tyrosine kinase inhibitors202010,266,513Bruton's tyrosine kinase inhibitors20197,105,559'Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade'20066,969,715'6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade'20056,828,338'Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade'20046,624,180'Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2006Patents assigned to PHARMACIA CORP (4)· patent assignee history
2003–2006Based in Ballwin, MO, US· patent location history
2019–2020Patents assigned to PFIZER (2)· patent assignee history
2019–2020Based in House Springs, MO, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHARMACIA CORP | 4 | 2003–2006 |
| PFIZER | 2 | 2019–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ballwin, MO, US | 4 | 2003–2006 |
| House Springs, MO, US | 2 | 2019–2020 |